CHEK2 GPV carrier status and family history of breast cancer were also examined as predictors of bilateral prophylactic mastectomy and bilateral prophylactic salpingo-oophorectomy in participants without a personal history of breast cancer. This evidence concerns the gene CHEK2 and breast carcinoma.